Marie Kosco-Vilbois
No más puestos en curso
Perfil
Marie Kosco-Vilbois is former Chief Scientific Officer for AC Immune SA, former Head-Immunology & Preclinical Pharmacology at Serono Pharmaceutical Research Institute, former Head-Immunology at Glaxo-Welcomes' Research Institute, former Chief Scientific Officer at NovImmune SA and former Scientific Member at Basel Institute for Immunology.
She received an undergraduate degree from Rutgers State University of New Jersey and a doctorate from Medical College of Virginia.
Antiguos cargos conocidos de Marie Kosco-Vilbois.
Empresas | Cargo | Fin |
---|---|---|
AC IMMUNE SA | Chief Tech/Sci/R&D Officer | 01/01/2024 |
NOVIMMUNE SA | Chief Tech/Sci/R&D Officer | 09/01/2019 |
Serono Pharmaceutical Research Institute | Corporate Officer/Principal | 01/01/2001 |
Basel Institute for Immunology | Corporate Officer/Principal | - |
Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | - |
Formación de Marie Kosco-Vilbois.
Rutgers State University of New Jersey | Undergraduate Degree |
Medical College of Virginia | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AC IMMUNE SA | Health Technology |
Empresas privadas | 3 |
---|---|
Novimmune SA
Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
Serono Pharmaceutical Research Institute | |
Glaxo-Welcomes' Research Institute |